Navigation Links
Building and Sustaining Impactful Competitive Intelligence Organizations for Pharma
Date:1/29/2008

CHAPEL HILL, N.C., Jan. 29 /PRNewswire/ -- In today's volatile business environment, unforeseen market shifts can blindside an unwary pharmaceutical company and nullify product forecasts, sales strategies and development plans. By delivering high-impact analyses on competitors' products and operations, a high-functioning Competitive Intelligence group can alert organizations to emerging market opportunities as well as warn them about potential external risks.

Competitive Intelligence groups in the pharma sector track an average of 23 competitors, according to new research by Best Practices, LLC. On the product side, the study found CI groups in pharma track an average of 49 products sold by competitors.

"An effective Competitive Intelligence group delivers guidance that gives a company a long-term competitive edge," said Cameron Tew, manager of research and publishing at Best Practices, LLC. "Both in terms of presenting opportunities and preparing for risks, the CI function provides key decision makers with actionable insights."

The cross-industry report, which presents data for the full benchmark class and pharmaceutical segment, is based on insights gathered from 54 organizations, with almost half of the companies from the pharmaceutical sector. Participants included Amgen, Eli Lilly, Roche, Sanofi-Aventis, Merck, Abbott and Wyeth.

A complimentary summary of "Building & Sustaining Impactful Competitive Intelligence Organizations" is available at http://www3.best-in-class.com/rr905.htm .

The comprehensive study covers everything from creating and structuring a CI group to developing high-impact CI activities and effective stakeholder relationships. The benchmarking study includes more than 500 metrics, including staffing and salary metrics. In addition to helping executives understand how to build an effective CI program, the study presents proven methods for increasing the quality and value of an existing CI group.

Some of the sample findings of the report include:

-- Winning CI organizations tie their goals to corporate business

objectives to assure that their deliverables will inform executives on

key issues and, ultimately, drive profitability.

-- Strategic planning and business development are the departmental homes

where interviewed executives think CI should reside.

-- The average CI operating budget is $821,613, although budgets varied

widely across study participants. The average salary for a CI head is

$148,709.

Download additional findings in the complimentary report summary at: http://www3.best-in-class.com/rr905.htm or contact our Solution Specialists at (919) 403-0251 or bestpractices@best-in-class.com.

If you would like to speak to us about how our research can benefit your Competitive Intelligence organization or other initiatives in your company, please contact Cameron Tew, Manager of Research and Publishing at Best Practices, LLC at (919) 767-9246 or ctew@best-in-class.com.

ABOUT BEST PRACTICES, LLC

Best Practices, LLC, conducts work based on the simple yet profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies. Best Practices, LLC has been a leader in pharmaceutical research and consulting for nearly 15 years; our clients include 43 out of the top 50 pharmaceutical companies.


'/>"/>
SOURCE Best Practices, LLC
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. New insight into factors that drive muscle-building stem cells
2. Pain treatment in the field: Good for soldiers comfort and better for rebuilding troop strength
3. Seasonal Sippers Supply Bone-Building Benefits
4. Building Better Launch Teams for Pharmaceutical Commercialization Success
5. Hidden Costs Plague Owners Occupying Newly Constructed Buildings; New Program Can Help Avoid Major Issues
6. Buildings Across The Country Join St. Jude Childrens Research Hospital(R) For Fourth Annual Thanks and Giving(R) Campaign, Asking America To Help Save Childrens Lives While Shopping For The Holidays
7. Advances in drug screening: building a better haystack for the needles of tomorrow
8. Mirixa Debuts RxFYI - a Free Pharmacy-Published Health eNewsletter Building Patient Loyalty and Generating Revenue
9. Building efficient, effective, locally sensitive solutions for dementia care
10. Medical Affairs: Building Efficient Medical Affairs Functions That Drive Product Marketing Success
11. Siemens Building Technologies Pioneers Wireless Solution for St. Anthonys Sensitive Environment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/16/2017)... Linda, Ca (PRWEB) , ... August 16, 2017 , ... ... innovators, engineers, and scientists from around the world, is excited to announce Andrew Ly ... him in his academic pursuits, covering textbook costs. , Ly, who is in ...
(Date:8/16/2017)... ... 16, 2017 , ... With a new PD diagnosis every nine minutes, research ... The grants are awarded through a competitive application process and reviewed by APDA’s Scientific ... and expertise in all areas relevant to PD research. The SAB meets annually ...
(Date:8/16/2017)... ... August 16, 2017 , ... Melbourne’s reign as the world’s most liveable city ... (EIU) annual Liveability Index. , The Index surveys 140 of the world’s cities and ... Melbourne has consistently come in the top three of the index. So what is ...
(Date:8/16/2017)... Fla. (PRWEB) , ... August 16, 2017 , ... ... and management company based in Vero Beach, announced today that two of their ... an organization that represents professionally managed senior living communities in Florida. The awards ...
(Date:8/16/2017)... City, Utah (PRWEB) , ... August 16, 2017 , ... ... on the Inc 5000 list for the fourth consecutive year. With 197% ... 5000 2017 list of the nation’s fastest growing companies. , Previous honors ...
Breaking Medicine News(10 mins):
(Date:8/15/2017)... Diplomat Pharmacy, Inc. (NYSE: DPLO), is now ... residents. Naloxone is available without a ... pharmacy, G-3320 Beecher Road. ... Administration, is intended to block or reverse the effects ... of consciousness. The medication is often carried by first ...
(Date:8/14/2017)... HACKENSACK, N.J. and PETACH TIKVAH, ... Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult ... for the second quarter ending June 30, 2017. ... advanced stages of preparing for our pivotal Phase 3 ... Chaim Lebovits , President and Chief Executive Officer ...
(Date:8/8/2017)... Second-quarter 2017 revenues of $876 ... from continuing operations Second-quarter ... $110 million Second-quarter 2017 ... Second-quarter 2017 adjusted diluted ... percent to $0.93 Second-quarter ...
Breaking Medicine Technology: